Nancy Walsh writing in MedPage Today reported, “Patients with rheumatoid arthritis (RA) undergoing treatment with agents such as Enbrel (etanercept), Remicade (infliximab) or Humira (adalimumab) appear to have a significantly increased risk for developing shingles,” according to a study published in the Annals of the Rheumatic Diseases. Researchers found that “the incidence of shingles among patients on anti-tumor necrosis factor (TNF) treatment was 1.6 per 100 patient-years, compared with an incidence of 0.8 per 100 patient-years among those receiving traditional disease-modifying anti-rheumatic drugs (DMARDs).”
Comment: What can I say? These are worrisome findings and indicate that people with RA on biologics should be vaccinated.
For more information on arthritis treatments and other arthritis problems, go to:
Just go here Contact